EORTC at ESMO 2017 in Madrid
1 Sep 2017
EORTC, in collaboration with ESMO and EACR, will present a session on tumours with rare oncogenic lesions: From pre-clinical to clinical validation on 10 September from 11:00 to 12:30.
Professor Françoise Meunier, Director of Special Projects at EORTC, will co-chair the Hans Keulen Memorial debate on Lost in rehabilitation on 11 September from 13:00 to 14:30; and Ms Anastassia Negrouk, Head of International Policy Office, will be a speaker at the Challenge Your Expert (CYE) session on the new EU clinical trials and data protection regulations. This session will take place on 11 September at 08:00.
EORTC will also be presenting three oral abstract session and five abstracts in poster sessions at ESMO (September 8-12, 2017) in Madrid.
Oral presentations
- Time to definitive failure to the first tyrosine kinase inhibitor in localized gastrointestinal stromal tumors (GIST) treated with imatinib as an adjuvant: final results of the EORTC STBSG, AGITG, UNICANCER, FSG, ISG, and GEIS randomized trial (Abstract LBA55)
Session: Sarcoma
Time: Saturday September 9, 11:00 to 12:30
Location: Granada Auditorium
Speaker: P.G. Casali
- Immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib (EORTC 30073 SURTIME) (Abstract LBA35)
Session: Genitourinary tumours, non-prostate
Time: Saturday September 9, 9:15 to 10:45
Location: Madrid Auditorium
Speaker: A. Bex
- Not all small node negative (pT1abN0) breast cancers are similar: Outcome results from the EORTC 10041/BIG 3-04 (MINDACT) trial (Abstract 150O)
Session: Breast cancer, early stage
Time: Friday September 8, 14:00 to 15:30
Location: Pamplona Auditorium
Speaker: K. Tryfonidis
Poster sessions
- EORTC experience with advanced/metastatic epithelioid sarcoma patients treated in prospective clinical trials: clinical profile and response to systemic therapy (Abstract 1496P)
Session: Poster Display session
Time: Monday September 11, 13:15 to 14:15
Location: Hall 8
Authors: Touati N, Schöffski P, Litière S, Judson I, Sleijfer S, van der Graaf WT, Italiano A, Isambert N, Gil T, Blay JY, Stark D, Brodowicz T, Marréaud S, Gronchi A
- Evolution in Neutrophil-to-lymphocyte ratio (NLR) among advanced Soft Tissue Sarcoma (STS) patients treated with pazopanib within EORTC 62043/62072 trials (Abstract 1502P)
Session: Poster Display session
Time: Monday September 11, 13:15 to 14:15
Location: Hall 8
Authors: De Maio E, Touati N, Litière S, Sleijfer S, van der Graaf WT, Le Cesne A, D’Ambrosio L, Casali PG, Italiano A, Desar I, Gronchi A
- Hope for salivary gland cancer (SGC): EORTC HNCG/UKCRN 1206 randomized phase II study to evaluate the efficacy and safety of Chemotherapy (CT) vs androgen deprivation therapy (ADT) in patients with recurrent and/or metastatic androgen receptor (AR) expressing SGC (Abstract 1106TIP)
Session: Poster Display session
Time: Sunday September 10, 13:15 to 14:15
Location: Hall 8
Authors: L.Locati, C.Caballero, C. Fortpied, F. Perrone, S. Pilotti, K.J. Harrington, V. Gregoire, L. Licitra
- Diagnostic and therapeutic strategies for elderly patients with advanced Non-Small cell lung cancer (NSCLC): results from an EORTC pan-european survey (Abstract 1371P)
Session: Poster Display session
Time: Saturday September 9, 13:15 to 14:15
Location: Hall 8
Authors: M. Giaj Levra, J. Menis, A. Luciani, E. De Maio, B. Hasan, T. Berghmans, M.A. Messiani, M. De Waele, A.-M. Dingemans, J. Donckele, C. Faivre-Finn, N. Girard, L. Greillier, S. Lantuéjoul, M. O’Brien, M. Reck, K. Tryfonidis, H. Wildiers, B. Besse, S. Novello
- Diversity of brain metastasis (BM) management in non-small cell lung cancer (NSCLC) in Europe (EU): Results of the Young Investigators European Organisation for Research and Treatment of Cancer Lung Cancer Group (YI EORTC LCG) survey (Abstract 1372P)
Session: Poster Display session
Time: Saturday September 9, 13:15 to 14:15
Location: Hall 8
Authors: Antonin Levy, Corinne Faivre-Finn, Baktiar Hasan, Eleonora De Maio, Anna S. Berghof, Anne-Marie Dingemans, Silvia Novello, Thierry Berghmans, Benjamin Besse, Lizza Hendriks
Related News
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026
EORTC’s presence at ESTRO 2026
30 Apr 2026
Independent, academic cancer trials are vital to improve patient outcomes worldwide
28 Apr 2026
EORTC Imaging Group Becomes the Diagnostic and Therapeutic Imaging Group
24 Apr 2026
Investing in the future of cancer research; EORTC’s Young and Early Career investigator Network shows its value
23 Apr 2026
In Memoriam of Martine Van Glabbeke (1951-2026)
17 Apr 2026
PEACE-3 trial demonstrates significant overall survival benefit in patients with metastatic castration-resistant prostate cancer with bone metastases
27 Feb 2026
EORTC celebrates Rare Disease Day: Addressing unmet needs in rare cancers
27 Feb 2026
First Site Activated in EORTC RENALUT Clinical Trial on Metastatic Clear Cell Renal Cell Carcinoma
26 Feb 2026
World Cancer Day: How clinical cancer research changes lives
4 Feb 2026
